Glycorex Transplantation Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Glycorex Transplantation
Access all reports
Glycorex Transplantation AB is a Swedish biotechnology company headquartered in Uppsala. It owns GlycoMab, a patented technology used to create antibodies that are immunosuppressive drugs like Atgam, which the company produces. The company also collaborates with third-party companies for the development and commercialization of other therapies.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
GTAB
Country
🇸🇪 Sweden